Virgin Atlantic Orders Drugs To Combat Avian Flu | Aero-News Network
Aero-News Network
RSS icon RSS feed
podcast icon MP3 podcast
Subscribe Aero-News e-mail Newsletter Subscribe

Airborne Unlimited -- Most Recent Daily Episodes

Episode Date

Airborne-Monday

Airborne-Tuesday

Airborne-Wednesday Airborne-Thursday

Airborne-Friday

Airborne On YouTube

Airborne-Unlimited-09.15.25

AirborneNextGen-
09.09.25

Airborne-Unlimited-09.10.25

Airborne-AffordableFlyers-09.11.25

AirborneUnlimited-09.12.25

Fri, Nov 04, 2005

Virgin Atlantic Orders Drugs To Combat Avian Flu

Carrier Purchases 10,000 Doses Of Antiviral Tamiflu

Britain's Virgin Atlantic Airways has ordered a stockpile of the antiviral drug Tamiflu to be used in case a human outbreak of avian flu sweeps through areas in which the carrier operates.

The move, billed "as a purely precautionary measure" in a Time magazine report, comes as cases of "bird flu" have already been reported in poultry in China, Malaysia and Japan.

While Virgin did not cite the specific amount ordered by the carrier, Time reported the 10,000 figure comes from Sir Richard Branson himself, who owns a majority stake of the airline he created in 1984.

Virgin does not currently serve the countries that have reported human cases of the disease so far -- Cambodia, Indonesia, Vietnam, and Thailand -- although the carrier does fly into Hong Kong, which reported human outbreaks of a bird flu strain eight years ago.

Virgin stresses there is no need to alter its routes at this time. "Virgin Atlantic is closely monitoring the spread of avian flu and is in regular contact with the (British) and U.S. governments," the company said Wednesday.

"At this stage, there is no need to change any advice to passengers traveling with Virgin Atlantic, or to alter any of the airline's procedures."

Virgin Atlantic said it was also "evaluating a range of other systems and measures" -- good thing, too, as it is unlikely any supplies of Tamiflu needed by the carrier would be available anytime soon.

The antiviral drug -- that is only produced by the Swiss pharmaceutical company Roche Group -- is already on backorder worldwide. According to the World Health Organization, it will take 10 years at current production rates to treat 20 percent of the world's population.

FMI: www.virginatlantic.com, www.who.org

Advertisement

More News

Classic Aero-TV: UAvionix - Transitioning Between Manned & Unmanned Technologies

From 2017 (YouTube Edition): ADS-B For Airplanes And Drones… ADS-B technology developed by uAvionix has come full circle. The company began with a device developed for manne>[...]

ANN's Daily Aero-Term (09.14.25): Dead Reckoning

Dead Reckoning Dead reckoning, as applied to flying, is the navigation of an airplane solely by means of computations based on airspeed, course, heading, wind direction, and speed,>[...]

Aero-News: Quote of the Day (09.14.25)

"The next great technological revolution in aviation is here. The United States will lead the way, and doing so will cement America’s status as a global leader in transportat>[...]

ANN's Daily Aero-Linx (09.14.25)

Aero Linx: The Mooney Mite Site Dedicated to the Mooney M-18 Mite, "The Most Personal Airplane," and to supporting Mite owners everywhere. The Mooney M-18 Mite is a single-place, l>[...]

Airborne-NextGen 09.09.25: Textron Nixes ePlane, Joby L/D Flt, Swift Approval

Also: Space Command Moves, Alpine Eagle, Duffy Names Amit Kshatriya, Sikorsky-CAL FIRE Collab Textron eAviation is putting the development of its Nexus electric vertical takeoff an>[...]

blog comments powered by Disqus



Advertisement

Advertisement

Podcasts

Advertisement

© 2007 - 2025 Web Development & Design by Pauli Systems, LC